Calendrier des promotions Biomerica, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.Paramètres de base
IPO date
2005-01-03
ISIN
US09061H3075
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 1.94 | 7 |
P/BV | 1.6 | 8 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | -50.43 | 0 |
ROE | -65.28 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | -0.131 | 10 |
Debt/Ratio | 0.0848 | 10 |
Debt/Equity | 0.404 | 10 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | -19.18 | 0 |
Rentabilité Ebitda, % | 215.42 | 10 |
Rentabilité EPS, % | 54.44 | 7 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 3.2 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 3.43 $ | 0 $ | 0 $ | -6.71 % | 0 % | 0 % |
common.calendar.number_days.30d | 3.11 $ | 3.2 $ | 3.43 $ | 2.89 % | 0 % | 0 % |
common.calendar.number_days.90d | 0.535 $ | 0.4201 $ | 3.88 $ | 498.13 % | 0 % | 0 % |
common.calendar.number_days.180d | 0.5226 $ | 0.3211 $ | 3.88 $ | 512.32 % | 0 % | 0 % |
common.calendar.number_days.1y | 0.46 $ | 0.266 $ | 3.88 $ | 595.65 % | 0 % | 0 % |
common.calendar.number_days.3y | 3.39 $ | 0.266 $ | 4.17 $ | -5.6 % | 0 % | 0 % |
common.calendar.number_days.5y | 8.98 $ | 0.266 $ | 12.04 $ | -64.37 % | 0 % | 0 % |
common.calendar.number_days.10y | 0.266 $ | 0.266 $ | 16 $ | 1203.01 % | 0 % | 0 % |
common.calendar.number_days.ytd | 0.4705 $ | 0.303 $ | 3.88 $ | 580.13 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Mr. Gary Lu CPA | Principal Accounting Officer & CFO | 260k | 1981 (44 année) |
Ms. Lucy Liu Ph.D. | Director of Manufacturing & Technical Operations | N/A | |
Mr. Robert W. Carlson | Chief Commercial Officer | N/A | |
Mr. Zackary S. Irani | CEO & Director | 1966 (59 années) | |
Mr. Allen C. Barbieri | Executive Vice-Chairman of the Board & Corporate Secretary | 1958 (67 années) |
Informations sur l'entreprise
Adresse: United States, Irvine. CA, 17571 Von Karman Avenue - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.biomerica.com
Site web: https://www.biomerica.com